Palmetto Pharmaceuticals, LLC
Records under this name other than patents Palmetto Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Palmetto Pharmaceuticals, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,936,635 | Bioresorbable nitric oxide agonist prodrug scaffolds for vascular stents Lapsed on the fee record Ended Jan 20, 2019 · USPTO record | Lapsed on the fee record | Ended Jan 20, 2019 | USPTO record |
| US 6,465,516 | Method of stimulating nitric oxide synthase Formerly held Term ended Term ended Apr 10, 2017 · USPTO record | Term ended | Term ended Apr 10, 2017 | USPTO record |
| US 6,239,172 | Formulations for treating disease and methods of using same Lapsed on the fee record Ended May 29, 2013 · USPTO record | Lapsed on the fee record | Ended May 29, 2013 | USPTO record |
| US 6,818,669 | Increasing cerebral bioavailability of drugs Lapsed on the fee record Ended Nov 16, 2012 · USPTO record | Lapsed on the fee record | Ended Nov 16, 2012 | USPTO record |
| US 7,381,731 | Pharmaceutical composition comprising citrulline Lapsed on the fee record Ended Jun 3, 2012 · USPTO record | Lapsed on the fee record | Ended Jun 3, 2012 | USPTO record |
| US 6,425,881 | Therapeutic mixture useful in inhibiting lesion formation after vascular injury Lapsed on the fee record Ended Jul 30, 2010 · USPTO record | Lapsed on the fee record | Ended Jul 30, 2010 | USPTO record |
| US 5,543,430 | Method and formulation of stimulating nitric oxide synthesis Term ended Term ended no later than Aug 6, 2016 · Low confidence | Term ended | Term ended no later than Aug 6, 2016 | Low confidence |
| US 5,767,160 | Method and formulation of stimulating nitric oxide synthesis Term ended Term ended no later than Jun 16, 2018 · Low confidence | Term ended | Term ended no later than Jun 16, 2018 | Low confidence |
| US 5,968,983 | Method and formulation for treating vascular disease Term ended Term ended no later than Oct 19, 2019 · Low confidence | Term ended | Term ended no later than Oct 19, 2019 | Low confidence |